SEC Form 4 · accession 0001140361-16-069502
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher T Cox
Officer — EVP & Chief Corp. Dev. Officer
Period of report
Jun 8, 2016
Accepted (ET)
Jun 10, 2016 · 7:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 8, 2016 | P | 25,975 | $38.43 | A | 52,315 | I | See footnote |
| Common StockF3,F2 | Jun 10, 2016 | P | 13,340 | $37.22 | A | 65,655 | I | See footnote |
| Common StockF4 | Jun 10, 2016 | P | 6,670 | $37.21 | A | 33,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price of the shares purchased ranging from a low of $38.32 to a high of $38.50 per share. The reporting person undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price for this footnote (1) and footnotes (3) and (4).
- F2The reporting person holds a power of attorney with respect to this account. Members of the reporting person's immediate family may be considered to have a pecuniary interest in this account. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein.
- F3Represents the weighted average purchase price of the shares purchased ranging from a low of $37.09 to a high of $37.46 per share.
- F4Represents the weighted average purchase price of the shares purchased ranging from a low of $37.10 to a high of $37.46 per share.